Running title: Rapid selection of randomly induced mutations using CRISPR/Cas9
Introduction
CRISPR/Cas9 based genome editing represents a significant advance within the field of genetics. In general, co-expression of Cas9 and an engineered single guide RNA (sgRNA) forms a sequence homology-dependent endonuclease that creates DNA doublestranded breaks (DSBs) within a specified target sequence (1) , and this has also been successfully used in Drosophila (2, 3) . DSBs can be repaired by the cell's endogenous DNA repair machinery, either through error-prone non-homologous end-joining (NHEJ), possibly resulting in mutations -small insertions or deletion, or through homology directed repair (HDR), which requires template DNA containing sequences homologous to the regions flanking the DSB. The CRISPR/Cas9 system is now routinely used to facilitate gene knockout and gene replacement strategies in various model genetic organisms (4) .
The CRISPR/Cas9 system is remarkable in that it allows the localization of a protein/RNA complex (Cas9 + sgRNA) to a specific sequence within the genome, as specified through a 17-20 nucleotide region of the sgRNA molecule. Being able to localize a protein to a specific DNA sequence opens up many new opportunities, and Cas9 has been modified to create several new tools and techniques. By mutating the catalytic sites of the Cas9 endonuclease, a catalytically inactive or "dead" Cas9 (dCas9) has been developed (5) . Various dCas9 fusion proteins have subsequently been designed, and the dCas9 system can be used for a variety of new applications, including the activation or repression of gene transcription, site-specific chromatin modification, or visualization of specific chromosome sites in living cells -see (6, 7) for reviews.
For Drosophila researchers, prior to the development of CRISPR/Cas9, targeted gene knockouts or gene replacement by homologous recombination were both possible, but challenging and labor intensive endeavors (8, 9) . CRISPR/Cas9 strategies for gene knockout and gene replacement are now common techniques for many Drosophila research groups. Building on the GAL4/UAS system of inducible gene expression, CRISPR/Cas9 approaches for tissue specific target gene knockdown or overexpression in Drosophila are now also possible; resources, including >1600 transgenic stocks expressing different sgRNAs made by the Drosophila RNAi Screening Center and Transgenic RNAi Project (DRSC/TRiP) are publically available -see (10) for overview of resources. In the case of targeted gene overexpression, the TRiP transgenic lines were designed to ubiquitously express two sgRNAs targeted to sequences upstream of a gene's transcriptional start site (TSS) (11, 12) . These lines are known as TRiP-OE, or TOE lines. Target gene overexpression is achieved by crossing a TOE line to a line that carries a GAL4 driver of one's choice and UAS-dCas9.VPR, which is dead-Cas9 fused to the VPR transcriptional activation domain. Other sgRNA lines known as TRiP-KO, or TKO lines, designed for gene knockout, ubiquitously express a single sgRNA targeted to the coding region of a GOI, and can be used to create germline or somatic mutations by crossing to a line that carries the appropriate GAL4 driver along with UAS-Cas9 (active Cas9), or a germline specific Cas9 construct (nos-Cas9 or vasa-Cas9).
We are interested in the regulation and function of the gene hindsight (hnt), which is the Drosophila homolog of mammalian Ras Responsive Element Binding Protein-1 (RREB-1) (13, 14) . Most mutations of hnt are recessive and embryonic lethal, and fail in the morphogenetic process of germ band retraction (15) . In this study we confirm hnt overexpression using a TRiP-OE sgRNA with GAL4 and UAS-dCas9.VPR. We also demonstrate that CRISPR/Cas9 mediated activation of gene expression is dose dependent and can be used as a new approach for the characterization of mutant alleles. Furthermore, we show that crossing a TOE-sgRNA line to a line having germline expression of active Cas9 can allow for the recovery of lines that are refractory to dCas9.VPR mediated activation of gene expression. Such refractory lines have mutated sgRNA target sequences, but are in all other respects wild type for hnt expression and function. We show that refractory alleles can be maintained as homozygous stocks with TOE-sgRNA + GAL4 + UAS-dCas9.VPR and show no overexpression phenotype.
Crossing these refractory lines to stocks that are responsive to dCas9.VPR-mediated activation of gene expression results in the reappearance of the overexpression phenotype in F1 progeny. If, however, the progeny of the same cross also carry a loss-of-function hnt allele, then the overexpression phenotype is abrogated. Building upon these observations, and as a proof of principle, we present the development of a new screening strategy that allows for the selection of randomly induced recessive lethal alleles in an F1 visible screen. Following EMS treatment of a responsive line, and crossing to the refractory line that carries TOE-sgRNA + GAL4 + UAS-dCas9.VPR, we screened for the absence of an overexpression phenotype and, in so doing, selected 8 new alleles of hnt from ~45,000 F1 progeny over a period of 2-3 weeks. We suggest that this method for the selection of randomly induced mutations in a GOI can be used in any context where Cas9-mediated activation of gene expression is associated with a phenotype (either visible or lethal). Such recovery of numerous mutant alleles in a GOI is potentially useful for analysis of mutation profiles, or the rapid recovery of an allelic series for a GOI.
Results
Previous work demonstrates CRISPR/Cas9 mediated in vivo activation of hnt expression. In this "proof-of-principle" example, ectopic hnt expression is shown in the third larval instar wing imaginal disc (11) . To further investigate CRISPR/Cas9 mediated overexpression of hnt, we used the TRiP-TOE insertion line TOE-GS00052, which ubiquitously expresses two sgRNAs, targeted to 110-129 bps and 183-203 bps upstream of the TSS of hnt (Fig. 1A) . Crossing line TOE-GS00052 to a line that carries the eye specific GMR-GAL4 driver and UAS-dCas9.VPR resulted in pupal lethality at 25°C, but viable and fertile adults with a strong rough eye phenotype at 18°C. The hnt overexpression phenotype, which we have also observed in the context of GMR-GAL4 > UAS-GFP-Hnt, is distinctive in that the eye margin is consistently more pigmented than the inner region, giving the appearance of dark rings around the eyes ( Fig. 1 B,C). We confirmed that the rough eye phenotype in the context of GAL4>UAS-dCas9.VPR + TOE-GSGS00052 is attributable to the overexpression of hnt by co-expression of UAShnt-RNAi, which resulted in a full suppression of the rough eye phenotype (Fig. 1E,F) .
The overexpression of hnt in the pupal eye is sensitive to gene dosage and temperature.
Through a series of crosses carried out at 18°C, we recovered a stock carrying all three transgenes required for CRISPR/Cas9 mediated activation of hnt expression in the pupal eye (i.e. GMR-GAL4, TOE-GS00052, and UAS-dCas9.VPR). When transferred to 25°C, this stock was 100% pupal lethal, with no adult escapers. To test the dosage responsiveness of hnt overexpression, we crossed males of the overexpression stock (reared at 18°C) to females carrying a balanced deletion of hnt (hnt is an X-linked gene, so the stock was Df(1)ED6727/FM7). Interestingly, at 25°C all progeny of this cross are FM7 + females and display the distinctive hnt overexpression rough eye phenotype, identical to hnt + /hnt + overexpression phenotype at 18°C. We subsequently found that other hnt alleles previously characterized as strong loss-of-function alleles (hnt XE81 , hnt 1142 , hnt 345x ) also behave the same way, and only produce FM7 + female progeny at 25°C ( Fig. 1D ). Other hnt alleles tested, including the hypomorphic semi-lethal allele hnt 308 , the temperature sensitive hypomorphic allele hnt peb , and the lethal allele hnt PL67 , do not produce progeny at 25°C.
The recovery of hnt alleles refractory to CRISPR/Cas9 mediated overexpression.
The above results suggest that suppression of dCas9.VPR mediated activation of gene expression could be used not only to characterize existing alleles, but to select newly induced loss-of-function mutations in a GOI. To be broadly applicable, however, it is necessary to recover GOI alleles that are refractory to CRISPR/Cas9 mediated activation of gene expression, but are in all other respects wild type. In general, such In order to recover hnt REF alleles (hnt alleles refractory to CRISPR/Cas9 mediated activation of gene expression -but otherwise wild type), we used the approach of transmitting the ubiquitously expressed TOE-sgRNA transgene GS00052 through the female germline with active Cas9 expression (crossing scheme is outlined in Fig. 2 ). In our case, we were able to cross such females to males carrying all three transgenes required for CRISPR/Cas9 mediated activation of gene expression of hnt in the pupal eye (i.e. the y w ; GMR-GAL4 TOE-GS00052 ; UAS-dCas9.VPR stock that is viable at 18°C).
Progeny of this cross that carried all three transgenes, but not displaying the overexpression phenotype were found in abundance. In order to recover isogenic refractory lines, single refractory males were crossed with FM7 females, and through selection and backcrossing, isogenic refractory lines devoid of the autosomal transgenes We found the RGV stock to be viable with no overexpression phenotype raised at 25°C. We also checked the RGV stock by crossing females to hnt + males (responsive to dCas9.VPR mediated activation of gene expression) and confirmed the expected phenotypes of viable female hnt + /hnt REF progeny displaying the overexpression eye phenotype and viable male hnt REF progeny with no overexpression phenotype. Likewise, we confirmed that hnt + /hnt + females crossed to RGV males results in only female progeny that display the overexpression phenotype. In addition, we also re-tested Df(1)ED6727 as well as the strong hnt alleles (hnt XE81 , hnt 1142 , hnt 345x ) by crossing females of these FM7 balanced lines to RGV males, which confirmed that An F1 visible screen for recessive lethal mutations of hnt using the RGV stock.
As a proof of principle, we used the RGV stock to screen for new mutant alleles of hnt induced by EMS mutagenesis. In the screen (outlined in Fig. 3 All new hnt mutant alleles were also confirmed by failure to complement the temperature sensitive hypomorphic allele hnt peb at the restrictive temperature of 29°C.
Using Ubi-DEcadherin-GFP, we imaged pupal eyes of all hnt peb /hnt new heteroallelic combinations at 25°C, which we found to be a more sensitive background for the hnt peb phenotype. The severity of each allele was ranked by quantification of cones cells, which invariably number four per ommatidium in wild type (Fig. 5A ). Mutant ommatidia frequently contain fewer than four cone cells per ommatidium ( Fig. 5B -D, white arrowheads). Occasionally mutant ommatidia were found to contain 5 or 6 cone cells; these likely result from ommatidial fusion as they also contain three rather than two primary pigment cells (Fig. 5C , yellow arrowheads). According to this analysis, none of the newly induced alleles is as severe as the Df(1)ED6727 control, suggesting that none correspond to a null allele. We subsequently performed immunostaining on all lines using both monoclonal and polyclonal anti-Hnt antibodies ( Table 1) . All alleles were found to be anti-Hnt positive using the polyclonal antibody. Interestingly, two alleles (hnt BHR49 and hnt WN52 ) were monoclonal negative but polyclonal positive, and although the polyclonal signal was expressed with correct tissue specificity, it did not show the normal nuclear localization of Hnt. Overall, these results further support the notion that none of these new hnt alleles corresponds to a null allele.
Discussion
In general, the approach of dCas9.VPR mediated expression of mutant alleles can be considered as a new method for characterizing alleles. In a way, this is similar to
Muller's classical test for hypomorphic alleles through the synthesis of duplications containing a third copy of the mutant allele being tested. In this case, a third copy of a hypomorphic allele is expected to ameliorate the mutant phenotype compared to the phenotype of the homozygous euploid mutant (16) . In the case of dCas9.VPR mediated activation of gene expression, if an overexpression phenotype is suppressed in mutant heterozygote (m/+) relative to the wild type homozygote (+/+), then two possibilities arise: 1) the mutant allele may not encode a functional protein; or 2) the mutant allele may be refractory to overexpression through mutation or deletion of its sgRNA target sequences. Although these two possibilities may not be mutually exclusive, sequencing the sgRNA target sequences of a mutant allele could rule out the second possibility and thereby suggest that a particular allele is associated with a disruption of the protein coding region of the GOI. The characterization of mutant alleles can be further improved if a refractory allele of the GOI is available (+ REF ) and the mutant is known to have intact sgRNA target sequences. In this situation, any phenotype resulting from CRISPR/Cas9 mediated activation of gene expression in the heterozygote (+ REF /m), would suggest that the mutant allele is able to express a protein that is fully or partially functional. In this case, the mutant is more likely to be hypomorphic in nature, and could be associated with reduced gene expression or reduced protein function. Consistent with this, we found that the allele hnt 308 was fully responsive to dCas9.VPR mediated activation of gene expression. This allele, which is associated with a P element insertion 226 base pairs upstream of the TSS of hnt, was previously characterized as hypomorphic and displays a lower level of hnt expression (17) . The dCas9.VPR activation of hnt 308 expression is consistent with the hypomorphic nature of this allele, but also indicates that the sgRNA target sequences on the hnt 308 chromosome are intact and that the protein coding region can produce Hnt product that is sufficient to generate the overexpression phenotype. The same interpretations also apply to the allele hnt PL67 , which is an enhancer trap line associated with embryonic lethality but is largely uncharacterized.
Considering the 8 new hnt alleles recovered, all showed a strong refractory phenotype in the cross to the RGV stock. However, we also isolated many F1 progeny that showed intermediate phenotypes. We were very interested in the possibility of recovering weak loss-of-function hnt alleles from these "hits", but none of these lines bred true as X-linked mutations. We were also aware of the possibility of recovering dose-dependent second site modifiers. Two such lines were indeed recovered that consistently resulted in an intermediate dCas9.VPR mediated hnt overexpression phenotype, but do not map to the X chromosome. Further analysis of these lines may allow us to identify genes that are required for the full penetrance of the hnt overexpression phenotype. Such genes may ultimately shed light on the pathways and target genes regulated by Hnt.
Can these techniques be generalized?
Overall, we have developed a new approach for characterizing existing alleles of a GOI, and we have invented a new way to recover randomly induced mutations in a GOI based on CRISPR/Cas9 mediated activation of gene expression. The generalization of these techniques, however, depends on the recovery of refractory alleles of the GOI -that is, alleles whose only phenotype is that of not being responsive to CRISPR/Cas9 mediated activation of gene expression. Two questions remain to be answered before this technique can be generalized. First, is it always possibly to create a refractory allele for a GOI, or is this only possible for certain genes? And second, if the overexpression phenotype for a GOI is not sensitive to temperature or gene dosage, would it still be possible to recover a refractory allele? The first question cannot be answered until CRISPR/Cas9 mediated activation of gene expression is used on more genes. In regards to the second question, it is clear that the development of our system was greatly enhanced by the striking temperature and gene dosage sensitivity of the hnt overexpression phenotype in the pupal eye. But what if just one copy of the GOI is sufficient to generate a lethal phenotype with the three overexpression components (sgRNA + GAL4 + UAS-dCas9.VPR)? If the structure of a gene is such that it can be mutated to create a refractory chromosome, it should be still be possible to select viable refractory alleles. One way this could be accomplished would be to recover refractory alleles heterozygous to a deletion of the GOI in the background of GAL4 > UAS-dCas9.VPR. Further studies will be required to determine if such techniques are feasible. 
Materials and Methods

Drosophila stocks
The chromosome used in the mutagenesis screen was w PBac{RB}e02388b (Exelixis at Harvard medical School #e02388). Pre-existing hnt alleles used included hnt XE81 , hnt 1142 , hnt 308 , and hnt 345x as previously described (15, (17) (18) (19) . Confocal imaging of pupal eye made use of Ubi-DE-cadherin-GFP as previously described (20) . Complementation crosses were facilitated by the transgenic line peb BAC-CH321-46J02 as described (19) . GAL4
> UAS based overexpression of hnt used UAS-GFP-hnt as previously described (21) .
This line UAS-GFP-Hnt, however, resulted in pupal lethality in combination with GMR-GAL4. To achieve lower levels of hnt overexpression not resulting in pupal lethality, the 
UAS-GFP-hnt insertion was mobilized by crossing to the transposase line
EMS Mutagenesis
3-5 day old males of the w PBac{RB}e02388b stock were collected and starved for 2 hours by placing in empty vials. Following starvation, male flies were transferred to bottles containing Kimwipe tissues soaked in a 2% sucrose solution containing 25 mM EMS (Sigma-Aldrich) and allowed to feed overnight. They were subsequently placed in vials with 3-5 day old virgin RGV females in crowded conditions and allowed to mate for 6-8 hours (30-40 virgin females with same number of males). Mated females and males were transferred to bottles for two days at which point they were removed.
Molecular Characterization of Refractory Mutants
In order to characterize refractory alleles we extracted genomic DNA from a pooled group of 20-30 isogenic male flies using gSYNC DNA Extraction Kits (Geneaid) according to supplier's instructions. We used 2.5 μ L of isolated genomic DNA in 25 μ L PCR reactions (2X FroggaMix; FroggaBio) utilizing primers flanking the guide target regions at ~400 bp upstream and downstream of the sgRNA target sequences. PCR products were purified using GenepHlow Gel/PCR Kits (Geneaid) then sent out for Sanger sequencing using both forward and reverse primers.
Complementation crosses
New hnt alleles, maintained as balanced lines over FM7h, were tested for complementation by crossing to hnt peb males at the restrictive temperature 29°C as well as males of the following genotype: y w hnt XE81 /Y; peb BAC-CH321-46J02 / TM6C, Sb. Failure to complement hnt peb was indicated by a rough eye phenotype, while failure to complement hnt XE81 was indicated by the absence of B + Sb female progeny carrying neither the FM7h balancer or the peb BAC insertion.
Immunostaining and Imaging
Immunostaining of embryos was carried out as described (17) . Primary antibodies were used at the indicated dilutions: mouse monoclonal anti-Hindsight (Hnt) 27B8 1G9 Confocal microscopy and confocal image processing were performed as previously described (22) . Eye micrographs (Fig. 1A,B ) were taken using a Nikon 
